αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH, Furukawa T, Degardin M, Sugyo A, Tsuji AB, Yamasaki T, Kawamura K, Fujibayashi Y, Zhang MR, Boturyn D, Dumy P, Saga T.
Jin ZH, et al.
Mol Cancer Ther. 2016 Sep;15(9):2076-85. doi: 10.1158/1535-7163.MCT-16-0040. Epub 2016 Jul 15.
Mol Cancer Ther. 2016.
PMID: 27422811